Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Sverre Kjeldsen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Double-Blind Method

Anatomy

Sympathetic Nervous System

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
75
Eide, Ivar
67
Julius, Stevo
62
Dahlöf, Björn
55
Os, Ingrid
42
Devereux, Richard
40
Oparil, Suzanne
40
Nieminen, Markku
37
Høieggen, Aud
35
Ibsen, Hans
33
Fossum, Eigil
33
Lindholm, Lars
33
moan, andreas
29
Wedel, Hans
28
Wachtell, Kristian
25
Omvik, Per

Sign-in to see all Coauthors

Publications

TOP 3
de Simone G; Okin P M; Gerdts E; Olsen M H; Wachtell K; Hille D A; Dahlöf B; Kjeldsen S E; Devereux R B
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study.
Madsen Steinar; Gjelsvik Bjørn; Kjeldsen Sverre E; Klemsdal Tor Ole; Meland Eivind; Narvesen Stein; Norheim Ole Frithjof; Njølstad Inger; Tonstad Serena; Ulvin Frøydis
[Solid guidelines for prevention of cardiovascular diseases]
Stepien Mariusz; Banach Maciej; Mikhailidis Dimitri P; Gluba Anna; Kjeldsen Sverre E; Rysz Jacek
Role and significance of statins in the treatment of hypertensive patients.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Sverre Kjeldsen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: de Simone G; Okin P M; Gerdts E; Olsen M H; Wachtell K; Hille D A; Dahlöf B; Kjeldsen S E; Devereux R B
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2009;19(9):634-40.
2009: Madsen Steinar; Gjelsvik Bjørn; Kjeldsen Sverre E; Klemsdal Tor Ole; Meland Eivind; Narvesen Stein; Norheim Ole Frithjof; Njølstad Inger; Tonstad Serena; Ulvin Frøydis
[Solid guidelines for prevention of cardiovascular diseases]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2009;129(16):1660.
2009: Stepien Mariusz; Banach Maciej; Mikhailidis Dimitri P; Gluba Anna; Kjeldsen Sverre E; Rysz Jacek
Role and significance of statins in the treatment of hypertensive patients.
Current medical research and opinion 2009;25(8):1995-2005.
2009: Tjugen Trygve B; Flaa Arnljot; Kjeldsen Sverre E
High heart rate as predictor of essential hypertension: the hyperkinetic state, evidence of prediction of hypertension, and hemodynamic transition to full hypertension.
Progress in cardiovascular diseases 2009;52(1):20-5.
2009: Zanchetti Alberto; Mancia Giuseppe; Black Henry R; Oparil Suzanne; Waeber Bernard; Schmieder Roland E; Bakris George L; Messerli Franz H; Kjeldsen Sverre E; Ruilope Luis M
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.
Journal of hypertension 2009;27(4):673-9.
2009: Okin Peter M; Oikarinen Lasse; Viitasalo Matti; Toivonen Lauri; Kjeldsen Sverre E; Nieminen Markku S; Edelman Jonathan M; Dahlöf Björn; Devereux Richard B;
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
Circulation 2009;119(14):1883-91.
2009: Olsen Michael Hecht; Wachtell Kristian; Beevers Gareth; Dahlöf Björn; de Simone Giovanni; Devereux Richard B; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kjeldsen Sverre E; Lederballe-Pedersen Ole; Lindholm Lars H; Lyle Paulette A; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2009;27(3):567-74.
2009: Zidek Walter; Naditch-Brûlé Lisa; Perlini Stefano; Farsang Csaba; Kjeldsen Sverre E
Blood pressure control and components of the metabolic syndrome: the GOOD survey.
Cardiovascular diabetology 2009;8():51.
2009: Oparil Suzanne; Kjeldsen Sverre E; Hedner Thomas; Narkiewicz Krzysztof
ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
Blood pressure 2009;18(1-2):4-6.
2008: Okin Peter M; Wachtell Kristian; Kjeldsen Sverre E; Julius Stevo; Lindholm Lars H; Dahlöf Björn; Hille Darcy A; Nieminen Markku S; Edelman Jonathan M; Devereux Richard B
Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Circulation. Arrhythmia and electrophysiology 2008;1(5):337-43.
2008: Hedner Thomas; Kjeldsen Sverre E; Narkiewicz Krzysztof; Oparil Susanne
More focus on therapeutic targets and improved tolerability in hypertension.
Blood pressure. Supplement 2008;2():3-4.
2008: Gudmundsdottir Helga; Strand Arne H; Kjeldsen Sverre E; Høieggen Aud; Os Ingrid
Serum phosphate, blood pressure, and the metabolic syndrome--20-year follow-up of middle-aged men.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(11):814-21.
2008: Ostergren Jan; Poulter Neil R; Sever Peter S; Dahlöf Björn; Wedel Hans; Beevers Gareth; Caulfield Mark; Collins Rory; Kjeldsen Sverre E; Kristinsson Arni; McInnes Gordon T; Mehlsen Jesper; Nieminen Markku; O'Brien Eoin;
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
Journal of hypertension 2008;26(11):2103-11.
2008: Kjeldsen Sverre E; Naditch-Brule Lisa; Perlini Stefano; Zidek Walter; Farsang Csaba
Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
Journal of hypertension 2008;26(10):2064-70.
2008: Flaa Arnljot; Aksnes Tonje A; Kjeldsen Sverre E; Eide Ivar; Rostrup Morten
Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study.
Metabolism: clinical and experimental 2008;57(10):1422-7.
2008: Flaa Arnljot; Eide Ivar K; Kjeldsen Sverre E; Rostrup Morten
Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study.
Hypertension 2008;52(2):336-41.
2008: Aksnes T A; Kjeldsen S E; Rostrup M; Störset O; Hua T A; Julius S
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial.
Journal of human hypertension 2008;22(8):520-7.
2008: Okin Peter M; Gerdts Eva; Kjeldsen Sverre E; Julius Stevo; Edelman Jonathan M; Dahlöf Björn; Devereux Richard B;
Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy.
Hypertension 2008;52(1):100-6.
2008: Aksnes Tonje A; Flaa Arnljot; Strand Arne; Kjeldsen Sverre E
Prevention of atrial fibrillation in hypertension.
Current hypertension reports 2008;10(3):175-81.
2008: Hedner Thomas; Oparil Suzanne; Narkiewicz Krzysztof; Kjeldsen Sverre E
Achieving better blood pressure control.
Blood pressure. Supplement 2008;1():3-4.
2008: Flaa Arnljot; Sandvik Leiv; Kjeldsen Sverre E; Eide Ivar K; Rostrup Morten
Does sympathoadrenal activity predict changes in body fat? An 18-y follow-up study.
The American journal of clinical nutrition 2008;87(6):1596-601.
2008: Li Zhibin; Dahlöf Björn; Okin Peter M; Kjeldsen Sverre E; Wachtell Kristian; Ibsen Hans; Nieminen Markku S; Jern Sverker; Devereux Richard B
Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
Journal of hypertension 2008;26(6):1244-9.
2008: Os Ingrid; Franco Veronica; Kjeldsen Sverre E; Manhem Karin; Devereux Richard B; Gerdts Eva; Hille Darcy A; Lyle Paulette A; Okin Peter M; Dahlöf Björn; Oparil Suzanne
Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Hypertension 2008;51(4):1103-8.
2008: Schmieder Roland E; Kjeldsen Sverre E; Julius Stevo; McInnes Gordon T; Zanchetti Alberto; Hua Tsushung A;
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.
Journal of hypertension 2008;26(3):403-11.
2008: Okin Peter M; Wachtell Kristian; Devereux Richard B; Nieminen Markku S; Oikarinen Lasse; Viitasalo Matti; Toivonen Lauri; Ibsen Hans; Olsen Michael H; Borch-Johnsen Knut; Lindholm Lars H; Kjeldsen Sverre E; Julius Stevo; Dahlöf Björn;
Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.
American journal of hypertension 2008;21(3):273-9.
2008: Cífková Renata; Mancia Giuseppe; Kjeldsen Sverre E; Laurent Stephane
European guidelines on cardiovascular disease prevention in clinical practice: past, present, and future: a need for joint forces.
Journal of hypertension 2008;26(2):157-60.
2008: Sever Peter S; Poulter Neil R; Dahlof Bjorn; Wedel Hans; Beevers Gareth; Caulfield Mark; Collins Rory; Kjeldsen Sverre E; Kristinsson Arni; McInnes Gordon; Mehlsen Jesper; Nieminen Markku S; O'Brien Eoin T; Ostergren Jan;
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.
European heart journal 2008;29(4):499-508.
2008: Strand A; Kjeldsen S E; Gudmundsdottir H; Os I; Smith G; Bjørnerheim R
Tissue Doppler imaging describes diastolic function in men prone to develop hypertension over twenty years.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2008;9(1):34-9.
2008: Kjeldsen Sverre E; Hedner Thomas; Narkiewicz Krzystof; Oparil Suzanne
More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
Blood pressure 2008;17(3):132-3.
2008: Hedner Thomas; Oparil Suzanne; Narkiewicz Krzysztof; Kjeldsen Sverre E
Achieving better blood pressure control.
Blood pressure 2008;17 Suppl 1():3-4.
2008: Kjeldsen Sverre E; McInnes Gordon T; Mancia Giuseppe; Hua Tsushung A; Julius Stevo; Weber Michael A; Coca Antonio; Girerd Xavier; Jamerson Kenneth; Larochelle Pierre; Macdonald Thomas; Schmieder Roland E; Anthony Schork M; Viskoper Reuven; Widimsky Jiri; Zanchetti Alberto
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial.
Blood pressure 2008;17(3):170-7.
2008: Gudmundsdottir Helga; Strand Arne H; Høieggen Aud; Reims Henrik M; Westheim Arne S; Eide Ivar K; Kjeldsen Sverre E; Os Ingrid
Do screening blood pressure and plasma catecholamines predict development of hypertension? Twenty-year follow-up of middle-aged men.
Blood pressure 2008;17(2):94-103.
2008: Kjeldsen Sverre E; Oparil Suzanne; Narkiewicz Krzysztof; Hedner Thomas
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET.
Blood pressure 2008;17(2):68-9.
2008: Kjeldsen Sverre E; Jamerson Kenneth A; Bakris George L; Pitt Bertram; Dahlöf Björn; Velazquez Eric J; Gupte Jitendra; Staikos Linda; Hua Tsushung A; Shi Victor; Hester Allen; Tuomilehto Jaakko; Ostergren Jan; Ibsen Hans; Weber Michael;
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
Blood pressure 2008;17(1):7-17.
2008: Hedner Thomas; Kjeldsen Sverre E; Narkiewicz Krzysztof; Oparil Suzanne
Urgent need to address quality control issues of out-of-office blood pressure measurement and patient risk assessment.
Blood pressure 2008;17(1):5-6.
2007: Aksnes Tonje Amb; Seljeflot Ingebjörg; Torjesen Peter A; Höieggen Aud; Moan Andreas; Kjeldsen Sverre E
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity.
Metabolism: clinical and experimental 2007;56(11):1470-7.
2007: Okin Peter M; Devereux Richard B; Harris Katherine E; Jern Sverker; Kjeldsen Sverre E; Lindholm Lars H; Dahlöf Björn;
In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.
Hypertension 2007;50(5):984-90.
2007: Hedner Thomas; Narkiewicz Krzysztof; Kjeldsen Sverre E
The evolution of ACE inhibition--a turning point in cardiovascular medicine.
Blood pressure. Supplement 2007;2():5-6.
2007: Fossum E; Gleim G W; Kjeldsen S E; Kizer J R; Julius S; Devereux R B; Brady W E; Hille D A; Lyle P A; Dahlöf B
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study.
Journal of internal medicine 2007;262(4):439-48.
2007: Okin Peter M; Devereux Richard B; Harris Katherine E; Jern Sverker; Kjeldsen Sverre E; Julius Stevo; Edelman Jonathan M; Dahlöf Björn;
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
Annals of internal medicine 2007;147(5):311-9.
2007: Mancia Giuseppe; De Backer Guy; Dominiczak Anna; Cifkova Renata; Fagard Robert; Germano Giuseppe; Grassi Guido; Heagerty Anthony M; Kjeldsen Sverre E; Laurent Stephane; Narkiewicz Krzysztof; Ruilope Luis; Rynkiewicz Andrzej; Schmieder Roland E; Boudier Harry Aj Struijker; Zanchetti Alberto;
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.
Journal of hypertension 2007;25(9):1751-62.
2007: Smebye Marianne L; Iversen Emil K; Høieggen Aud; Flaa Arnljot; Os Ingrid; Kjeldsen Sverre E; Olsen Michael Hecht; Chattopadhyay Arghya; Hille Darcy A; Lyle Paulette A; Devereux Richard B; Dahlöf Björn
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study).
The American journal of cardiology 2007;100(5):855-9.
2007: Aksnes Tonje A; Kjeldsen Sverre E; Rostrup Morten; Omvik Per; Hua Tsushung A; Julius Stevo
Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population.
Hypertension 2007;50(3):467-73.
2007: Wachtell Kristian; Okin Peter M; Olsen Michael H; Dahlöf Björn; Devereux Richard B; Ibsen Hans; Kjeldsen Sverre E; Lindholm Lars H; Nieminen Markku S; Thygesen Kristian
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
Circulation 2007;116(7):700-5.
2007: de Simone G; Olsen M H; Wachtell K; Hille D A; Dahlöf B; Ibsen H; Kjeldsen S E; Lyle P A; Devereux R B
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
Journal of human hypertension 2007;21(8):625-32.
2007: Flaa Arnljot; Aksnes Tonje Amb; Strand Arne; Kjeldsen Sverre Erik
Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials.
Expert review of cardiovascular therapy 2007;5(3):451-61.
2007: Strand Arne H; Gudmundsdottir Helga; Fossum Eigil; Os Ingrid; Bjørnerheim Reidar; Kjeldsen Sverre E
Arterial plasma vasopressin and aldosterone predict left ventricular mass in men who develop hypertension over 20 years.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(5):365-71.
2007: Eid Hilde Marie Angell; Reims Henrik; Arnesen Harald; Kjeldsen Sverre Erik; Lyberg Torstein; Seljeflot Ingebjørg
Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia.
Metabolism: clinical and experimental 2007;56(4):464-9.
2007: Hedner Thomas; Narkiewicz Krzysztof; Kjeldsen Sverre E
There is a need for more aggressive implementation of combination strategies to control hypertensive risk.
Blood pressure. Supplement 2007;1():4-5.
2007: Pedersen Ole Lederballe; Mancia Giuseppe; Pickering Thomas; Høegholm Asbjørn; Julius Stevo; Kjeldsen Sverre E; Nielsen Eric S; Refsgaard Jens; Weber Michael;
Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy.
Journal of hypertension 2007;25(3):707-12.
2007: Devereux Richard B; de Faire Ulf; Fyhrquist Frej; Harris Katherine E; Ibsen Hans; Kjeldsen Sverre E; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Hille Darcy A; Dahlöf Björn
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Current medical research and opinion 2007;23(2):259-70.
2007: Jonsson Gisli; Abdelnoor Michael; Seljeflot Ingebjorg; Arnesen Harald; Hostmark Arne T; Kjeldsen Sverre E; Os Ingrid; Westheim Arne S
The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients.
Journal of cardiovascular pharmacology 2007;49(1):27-32.
2007: Aksnes Tonje A; Flaa Arnljot; Strand Arne; Kjeldsen Sverre E
Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
Journal of hypertension 2007;25(1):15-23.
2007: Kjeldsen Sverre E; Oparil Suzanne; Narkiewicz Krzysztof; Hedner Thomas
Ambulatory blood pressure adds to explaining benefits of AT-1 receptor blockade in the treatment of left ventricular hypertrophy.
Blood pressure 2007;16(6):344-6.
2007: Narkiewicz Krzysztof; Kjeldsen Sverre E; Oparil Suzanne; Hedner Thomas
Hypertension and cardiovascular disease: is arterial stiffness the heart of the matter?
Blood pressure 2007;16(4):236-7.
2007: Hedner Thomas; Narkiewicz Krzysztof; Kjeldsen Sverre E
The evolution of ACE inhibition - A turning point in cardiovascular medicine.
Blood pressure 2007;16 Suppl 2():5-6.
2007: Mansia Giuseppe; De Backer Guy; Dominiczak Anna; Cifkova Renata; Fagard Robert; Germano Giuseppe; Grassi Guido; Heagerty Anthony M; Kjeldsen Sverre E; Laurent Stephane; Narkiewicz Krzysztof; Ruilope Luis; Rynkiewicz Andrzej; Schmieder Roland E; Struijker Boudier Harry A; Zanchetti Alberto;
2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Blood pressure 2007;16(3):135-232.
2007: Hedner T Thomas; Narkiewicz Krzysztof; Kjeldsen Sverre E; Oparil Suzanne;
New ESH/ESC guidelines signal progress in hypertension management.
Blood pressure 2007;16(3):132-4.
2007: Kjeldsen Sverre E; Lyle Paulette A; Kizer Jorge R; Oparil Suzanne; Høieggen Aud; Os Ingrid
Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke.
Vascular health and risk management 2007;3(3):299-305.
2007: Jamerson Kenneth; Bakris George L; Dahlöf Björn; Pitt Bertram; Velazquez Eric; Gupte Jitendra; Lefkowitz Martin; Hester Allen; Shi Victor; Kjeldsen Sverre E; Cushman William; Papademetriou Vasilios; Weber Michael;
Exceptional early blood pressure control rates: the ACCOMPLISH trial.
Blood pressure 2007;16(2):80-6.
2007: Ruilope Luis; Kjeldsen Sverre E; de la Sierra Alejandro; Mancia Giuseppe; Ruggenenti Piero; Stergiou George S; Bakris George L; Giles Thomas D
The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension.
Blood pressure 2007;16(2):72-9.
2007: Hedner Thomas; Kjeldsen Sverre E; Narkiewicz Krzysztof; Oparil Susanne
Blood pressure control--slowly getting there through new strategies?
Blood pressure 2007;16(2):68-71.
2007: Hedner Thomas; Narkiewicz Krzysztof; Kjeldsen Sverre E
There is a need for more aggressive implementation of combination strategies to control hypertensive risk.
Blood pressure 2007;16 Suppl 1():4-5.
2007: Weber Michael A; Bakris George L; Dahlöf Björn; Pitt Bertram; Velazquez Eric; Gupte Jitendra; Lefkowitz Martin; Hester Allen; Shi Victor; Weir Matthew; Kjeldsen Sverre; Massie Barry; Nesbitt Shawna; Ofili Elizabeth; Jamerson Kenneth
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
Blood pressure 2007;16(1):13-9.
2007: Dahlöf Björn; Devereux Richard B; Kjeldsen Sverre E; Lyle Paulette A; Zhang Zhongxin; Edelman Jonathan M
Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
Blood pressure 2007;16(1):6-12.
2007: Kjeldsen Sverre E; Oparil Suzanne; Hedner Thomas; Narkiewicz Krzysztof
Documentation of endpoint prevention with combination therapy in hypertension is urgently needed.
Blood pressure 2007;16(1):4-5.
2007: Flaa Arnljot; Ekeberg Oivind; Kjeldsen Sverre Erik; Rostrup Morten
Personality may influence reactivity to stress.
BioPsychoSocial medicine 2007;1():5.
2006: Sever Peter; Dahlöf Björn; Poulter Neil; Wedel Hans; Beevers Gareth; Caulfield Mark; Collins Rory; Kjeldsen Sverre; Kristinsson Arni; McInnes Gordon; Mehlsen Jesper; Nieminem Markku; O'Brien Eoin; Ostergren Jan;
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial.
European heart journal 2006;27(24):2982-8.
2006: Larstorp Anne Cecilie K; Lund Søraas Camilla; Tønnessen Theis; Müller Carl; Kjeldsen Sverre E; Mangschau Arild
Scintigraphic demonstration of myocardial perfusion and ischaemia associated with coronary artery bypass grafting.
Scandinavian cardiovascular journal : SCJ 2006;40(6):354-62.
2006: Nilsson Peter M; Cifkova Renata; Kjeldsen Sverre E; Mancia Guiseppe
European Society of Hypertension Scientific Newsletter: update on hypertension management: prevention of type 2 diabetes mellitus with antihypertensive drugs.
Journal of hypertension 2006;24(12):2478-82.
2006: Zanchetti Alberto; Julius Stevo; Kjeldsen Sverre; McInnes Gordon T; Hua Tsushung; Weber Michael; Laragh John H; Plat Francis; Battegay Edouard; Calvo-Vargas Cesar; Cieslinski Andrzej; Degaute Jean Paul; Holwerda Nicolaas J; Kobalava Janna; Pedersen Ole Lederballe; Rudyatmoko Faustinus P; Siamopoulos Kostas C; Störset Oyvind
Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
Journal of hypertension 2006;24(11):2163-8.
2006: Aksnes T A; Reims H M; Guptha S; Moan A; Os I; Kjeldsen S E
Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
Journal of human hypertension 2006;20(11):860-6.
2006: Okin Peter M; Wachtell Kristian; Devereux Richard B; Harris Katherine E; Jern Sverker; Kjeldsen Sverre E; Julius Stevo; Lindholm Lars H; Nieminen Markku S; Edelman Jonathan M; Hille Darcy A; Dahlöf Björn
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
JAMA : the journal of the American Medical Association 2006;296(10):1242-8.
2006: Julius Stevo; Weber Michael A; Kjeldsen Sverre E; McInnes Gordon T; Zanchetti Alberto; Brunner Hans R; Laragh John; Schork M Anthony; Hua Tsushung A; Amerena John; Balazovjech Ivan; Cassel Graham; Herczeg Bela; Koylan Nevres; Magometschnigg Dieter; Majahalme Silja; Martinez Felipe; Oigman Willie; Seabra Gomes Ricardo; Zhu Jun-ren
The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy.
Hypertension 2006;48(3):385-91.
2006: Olsen Michael H; Wachtell Kristian; Nielsen Olav W; Hall Christian; Wergeland Ragnhild; Ibsen Hans; Kjeldsen Sverre E; Devereux Richard B; Dahlöf Björn; Hildebrandt Per R
N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Journal of hypertension 2006;24(8):1531-9.
2006: Kjeldsen Sverre E; Strand Arne; Julius Stevo; Okin Peter M
Mechanism of angiotensin II type 1 receptor blocker action in the regression of left ventricular hypertrophy.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(7):487-92.
2006: Kjeldsen Sverre E; Julius Stevo; Mancia Giuseppe; McInnes Gordon T; Hua Tsushung; Weber Michael A; Coca Antonio; Ekman Steffan; Girerd Xavier; Jamerson Kenneth; Larochelle Pierre; MacDonald Thomas M; Schmieder Roland E; Schork M Anthony; Stolt Pelle; Viskoper Reuven; Widimský Jiri; Zanchetti Alberto;
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.
Journal of hypertension 2006;24(7):1405-12.
2006: Os Ingrid; Gudmundsdottir Helga; Kjeldsen Sverre E; Oparil Suzanne
Treatment of isolated systolic hypertension in diabetes mellitus type 2.
Diabetes, obesity & metabolism 2006;8(4):381-7.
2006: Erdine Serap; Ari Oben; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn K H; Rodicio J L; Ruilope L M; Staessen J; van Zwieten P; Waeber B; Williams B
ESH-ESC guidelines for the management of hypertension.
Herz 2006;31(4):331-8.
2006: Flaa Arnljot; Kjeldsen Sverre E
Are all the hypertensives made equal?
Herz 2006;31(4):323-30.
2006: Strand Arne H; Gudmundsdottir Helga; Os Ingrid; Smith Gunnar; Westheim Arne S; Bjørnerheim Reidar; Kjeldsen Sverre E
Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years.
Journal of hypertension 2006;24(5):905-13.
2006: Mistry Nisha B; Westheim Arne S; Kjeldsen Sverre E
The angiotensin receptor antagonist valsartan: a review of the literature with a focus on clinical trials.
Expert opinion on pharmacotherapy 2006;7(5):575-81.
2006: Olsen Michael H; Wachtell Kristian; Ibsen Hans; Lindholm Lars H; Dahlöf Björn; Devereux Richard B; Kjeldsen Sverre E; Oikarinen Lasse; Okin Peter M;
Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
Journal of hypertension 2006;24(4):775-81.
2006: Palatini Paolo; Benetos Athanase; Grassi Guido; Julius Stevo; Kjeldsen Sverre E; Mancia Giuseppe; Narkiewicz Krzystof; Parati Gianfranco; Pessina Achille C; Ruilope Luis M; Zanchetti Alberto;
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting.
Journal of hypertension 2006;24(4):603-10.
2006: Okin Peter M; Devereux Richard B; Gerdts Eva; Snapinn Steven M; Harris Katherine E; Jern Sverker; Kjeldsen Sverre E; Julius Stevo; Edelman Jonathan M; Lindholm Lars H; Dahlöf Björn;
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
Circulation 2006;113(12):1588-96.
2006: Fossum Eigil; Olsen Michael Hecht; Høieggen Aud; Wachtell Kristian; Reims Henrik M; Kjeldsen Sverre E; Ibsen Hans; Wan Ying; Julius Stevo
Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(3):169-73.
2006: Flaa Arnljot; Mundal Håvard H; Eide Ivar; Kjeldsen Sverre; Rostrup Morten
Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges.
Hypertension 2006;47(3):396-402.
2006: Okin Peter M; Devereux Richard B; Nieminen Markku S; Jern Sverker; Oikarinen Lasse; Viitasalo Matti; Toivonen Lauri; Kjeldsen Sverre E; Dahlöf Björn;
Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
Circulation 2006;113(1):67-73.
2006: Nilsson Peter M; Cifkova Renata; Kjeldsen Sverre E
Update on Hypertension Management: treatment of hypertension in patients with type 2 diabetes mellitus.
Journal of hypertension 2006;24(1):208-10.
2006: Kjeldsen Sverre E; Narkiewicz Krzysztof; Cífková Renata; Mancia Giuseppe
ESH statement on detection and punishment of abstract fraud and poster plagiarism.
Journal of hypertension 2006;24(1):203-4.
2006: Narkiewicz Krzysztof; Kjeldsen Sverre E; Oparil Suzanne; Hedner Thomas
Beta-blockers as sub-optimal treatment for hypertension: time for first-line therapy revision?
Blood pressure 2006;15(6):323-4.
2006: Hedner Thomas; Narkiewicz Krzysztof; Oparil Suzanne; Kjeldsen Sverre E
The question of whether diabetes and its cardiovascular risks can be prevented: a realistic DREAM?
Blood pressure 2006;15(5):260-2.
2006: Nilsson Peter M; Cifkova Renata; Kjeldsen Sverre E; Mancia Giuseppe
Prevention of type 2 diabetes mellitus with antihypertensive drugs.
Blood pressure 2006;15(4):253-4.
2006: Christensen Marina K; Olsen Michael H; Wachtell Kristian; Tuxen Christian; Fossum Eigil; Bang Lia E; Wiinberg Niels; Devereux Richard B; Kjeldsen Sverre E; Hildebrandt Per; Rokkedal Jens; Ibsen Hans
Does long-term losartan- vs atenolol-based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy.
Blood pressure 2006;15(4):198-206.
2006: Hedner Thomas; Narkiewicz Krzysztof; Kjeldsen Sverre E
Medical decision making in hypertension.
Blood pressure 2006;15(4):196-7.
2006: Kjeldsen Sverre E; Narkiewicz Krzysztof; Hedner Thomas
An American TROPHY in the prevention of hypertension.
Blood pressure 2006;15(3):132-4.
2006: Mistry Nisha B; Westheim Arne S; Kjeldsen Sverre E
Treatment of hypertension in patients with congestive cardiac failure.
Heart failure monitor 2006;5(2):38-43.
2006: Aksnes Tonje Amb; Kjeldsen Sverre Erik; Mancia Giuseppe
The effect of antihypertensive agents on new-onset diabetes mellitus: time to amend the guidelines?
American journal of cardiovascular drugs : drugs, devices, and other interventions 2006;6(3):139-47.
2006: Kjeldsen Sverre E; Knudsen Karl; Ekrem Gunhild; Fure Tormod O; Movinckel Petter; Erikssen Jan E
Is there an association between severe job strain, transient rise in blood pressure and increased mortality?
Blood pressure 2006;15(2):93-100.
2006: Narkiewicz Krzysztof; Kjeldsen Sverre E; Hedner Thomas
Hypertension and cardiovascular disease in women: progress towards better understanding of gender-specific differences?
Blood pressure 2006;15(2):68-70.
2006: Jonsson Gisli; Abdelnoor Michael; Landaas Sverre; Muller Carl; Kjeldsen Sverre Erik; Os Ingrid; Westheim Arne
N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.
Cardiology 2006;106(2):102-8.
2006: Nilsson peter M; Cifkova Renata; Kjeldsen Sverre E
Treatment of Hypertension in patients with type-2 diabetes mellitus.
Blood pressure 2006;15(1):62-3.
2006: Hedner Thomas; Kjeldsen Sverre E; Narkiewicz Krzysztof
RAAS inhibition - a practice of medical progress.
Blood pressure 2006;15 Suppl 1():5-6.
2006: Hedner Thomas; Narkiewicz Krzysztof; Kjeldsen Sverre E
Cost-effectiveness of blood pressure measurement and hypertension follow-up.
Blood pressure 2006;15(1):4-5.
2005: Kjeldsen Sverre E; Westheim Arne S; Os Ingrid
More heat to support aggressive blood pressure lowering: the FEVER study.
Journal of hypertension 2005;23(12):2145-6.
2005: Kjeldsen Sverre E; Lyle Paulette A; Tershakovec Andrew M; Devereux Richard B; Oparil Suzanne; Dahlöf Björn; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Wedel Hans
Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Expert opinion on emerging drugs 2005;10(4):729-45.
2005: Poulter Neil R; Wedel Hans; Dahlöf Björn; Sever Peter S; Beevers D Gareth; Caulfield Mark; Kjeldsen Sverre E; Kristinsson Arni; McInnes Gordon T; Mehlsen Jesper; Nieminen Markku; O'Brien Eoin; Ostergren Jan; Pocock Stuart;
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
Lancet 2005;366(9489):907-13.
2005: Dahlöf Björn; Sever Peter S; Poulter Neil R; Wedel Hans; Beevers D Gareth; Caulfield Mark; Collins Rory; Kjeldsen Sverre E; Kristinsson Arni; McInnes Gordon T; Mehlsen Jesper; Nieminen Markku; O'Brien Eoin; Ostergren Jan;
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Lancet 2005;366(9489):895-906.
2005: Fossum Eigil; Moan Andreas; Kjeldsen Sverre E; Devereux Richard B; Julius Stevo; Snapinn Steven M; Edelman Jonathan M; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Dahlöf Björn;
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;46(5):770-5.
2005: Franklin Stanley S; Wachtell Kristian; Papademetriou Vasilios; Olsen Michael H; Devereux Richard B; Fyhrquist Frej; Ibsen Hans; Kjeldsen Sverre E; Dahlöf Björn
Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy.
Hypertension 2005;46(3):492-9.
2005: Aksnes Tonje Amb; Reims Henrik M; Kjeldsen Sverre E; Mancia Giuseppe
Antihypertensive treatment and new-onset diabetes mellitus.
Current hypertension reports 2005;7(4):298-303.
2005: Hedner Thomas; Narkiewicz Krzysztof; Kjeldsen Sverre E
Hypertension control- A global challenge.
Blood pressure. Supplement 2005;1():4-5.
2005: Reims Henrik M; Kjeldsen Sverre E; Mancia Giuseppe
Home blood pressure monitoring.
Journal of hypertension 2005;23(7):1437-9.
2005: Kjeldsen Sverre E; Westheim Arne S; Os Ingrid
Prevention of cardiovascular events and diabetes with angiotensin-receptor blockers in hypertension: LIFE, SCOPE, and VALUE.
Current hypertension reports 2005;7(3):155-7.
2005: Høieggen Aud; Os Ingrid; Kjeldsen Sverre E
[Uric acid--more deleterious than we thought?]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(10):1330-2.
2005: Sever Peter S; Poulter Neil R; Dahlöf Björn; Wedel Hans; Collins Rory; Beevers Gareth; Caulfield Mark; Kjeldsen Sverre E; Kristinsson Arni; McInnes Gordon T; Mehlsen Jesper; Nieminen Markku; O'Brien Eoin; Ostergren Jan
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).
Diabetes care 2005;28(5):1151-7.
2005: de Simone Giovanni; Wachtell Kristian; Palmieri Vittorio; Hille Darcy A; Beevers Gareth; Dahlöf Björn; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Julius Stevo; Kjeldsen Sverre E; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Devereux Richard B
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
Circulation 2005;111(15):1924-31.
2005: Fyhrquist Frej; Dahlöf Björn; Devereux Richard B; Kjeldsen Sverre E; Julius Stevo; Beevers Gareth; de Faire Ulf; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Hille Darcy A; Lyle Paulette A; Edelman Jonathan M; Snapinn Steven M; Wedel Hans;
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
Hypertension 2005;45(4):580-5.
2005: Olsen Michael H; Fossum Eigil; Høieggen Aud; Wachtell Kristian; Hjerkinn Elsa; Nesbitt Shawna D; Andersen Ulrik B; Phillips Robert A; Gaboury Cynthia L; Ibsen Hans; Kjeldsen Sverre E; Julius Stevo
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy.
Journal of hypertension 2005;23(4):891-8.
2005: Olsen M H; Christensen M K; Wachtell K; Tuxen C; Fossum E; Bang L E; Wiinberg N; Devereux R B; Kjeldsen S E; Hildebrandt P; Dige-Petersen H; Rokkedal J; Ibsen H
Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy.
Journal of human hypertension 2005;19(4):301-7.
2005: Kjeldsen Sverre E; Lyle Paulette A; Kizer Jorge R; Dahlöf Björn; Devereux Richard B; Julius Stevo; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Snapinn Steven M; Harris Katherine E; Wedel Hans;
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(3):152-8.
2005: Wachtell Kristian; Lehto Mika; Gerdts Eva; Olsen Michael H; Hornestam Björn; Dahlöf Björn; Ibsen Hans; Julius Stevo; Kjeldsen Sverre E; Lindholm Lars H; Nieminen Markku S; Devereux Richard B
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):712-9.
2005: Wachtell Kristian; Hornestam Björn; Lehto Mika; Slotwiner David J; Gerdts Eva; Olsen Michael H; Aurup Peter; Dahlöf Björn; Ibsen Hans; Julius Stevo; Kjeldsen Sverre E; Lindholm Lars H; Nieminen Markku S; Rokkedal Jens; Devereux Richard B
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):705-11.
2005: Kjeldsen Sverre E
[Misinterpretation of research]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(3):327.
2005: Ibsen Hans; Olsen Michael H; Wachtell Kristian; Borch-Johnsen Knut; Lindholm Lars H; Mogensen Carl Erik; Dahlöf Björn; Devereux Richard B; de Faire Ulf; Fyhrquist Frej; Julius Stevo; Kjeldsen Sverre E; Lederballe-Pedersen Ole; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wan Ying
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
Hypertension 2005;45(2):198-202.
2005: Kizer Jorge R; Dahlöf Björn; Kjeldsen Sverre E; Julius Stevo; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Wachtell Kristian; Edelman Jonathan M; Snapinn Steven M; Harris Katherine E; Devereux Richard B
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
Hypertension 2005;45(1):46-52.
2005: Kjeldsen Sverre E; Narkiewicz Krzysztof; Cifková Renata; Mancia Giuseppe
ESH statement on detection and punishment of abstract fraud and poster plagiarism.
Blood pressure 2005;14(6):322-3.
2005: Kjeldsen Sverre E; Narkiewicz Krzysztof; Hedner Thomas
ASCOT - more than a horse race!
Blood pressure 2005;14(5):262-3.
2005: Narkiewicz Krzysztof; Kjeldsen Sverre E; Hedner Thomas
Hypertension and coronary artery disease: mechanistic insights and therapeutic challenges.
Blood pressure 2005;14(5):260-1.
2005: Reims Henrik M; Sevre Knut; Fossum Eigil; Mellem Harald; Eide Ivar K; Kjeldsen Sverre E
Adrenaline during mental stress in relation to fitness, metabolic risk factors and cardiovascular responses in young men.
Blood pressure 2005;14(4):217-26.
2005: Kjeldsen Sverre E; Hedner Thomas; Narkiewicz Krzysztof
Angiotensin receptor blockers and endpoint protection.
Blood pressure 2005;14(4):195.
2005: Reims Henrik M; Sevre Knut; Høieggen Aud; Fossum Eigil; Eide Ivar; Kjeldsen Sverre E
Blood viscosity: effects of mental stress and relations to autonomic nervous system function and insulin sensitivity.
Blood pressure 2005;14(3):159-69.
2005: Hedner Thomas; Kjeldsen Sverre E; Narkiewicz Krzysztof
Health economy of the metabolic syndrome pandemic.
Blood pressure 2005;14(3):131-2.
2005: Narkiewicz Krzysztof; Kjeldsen Sverre E; Hedner Thomas
Is smoking a causative factor of hypertension?
Blood pressure 2005;14(2):69-71.
2005: Hedner Thomas; Narkiewicz Krzysztof; Kjeldsen Sverre E
Hypertension control - a global challenge.
Blood pressure 2005;14 Suppl 1():4-5.
2005: Jonsson Gisli; Abdelnoor Michael; Müller Carl; Kjeldsen Sverre Erik; Os Ingrid; Westheim Arne
A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients.
Cardiology 2005;103(3):148-55.
2005: Kjeldsen Sverre E; Os Ingrid; Høieggen Aud; Beckey Kim; Gleim Gilbert W; Oparil Suzanne
Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2005;5(1):17-22.
2004: Okin Peter M; Devereux Richard B; Jern Sverker; Kjeldsen Sverre E; Julius Stevo; Nieminen Markku S; Snapinn Steven; Harris Katherine E; Aurup Peter; Edelman Jonathan M; Wedel Hans; Lindholm Lars H; Dahlöf Björn;
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
JAMA : the journal of the American Medical Association 2004;292(19):2343-9.
2004: Kjeldsen Sverre E; Julius Stevo
Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
American heart journal 2004;148(5):747-54.
2004: Kjeldsen Sverre Erik
[Failing basis for the use of thiazides]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(20):2659-60.
2004: Reims Henrik M; Sevre Knut; Fossum Eigil; Høieggen Aud; Mellem Harald; Kjeldsen Sverre E
Relations between insulin sensitivity, fitness and autonomic cardiac regulation in healthy, young men.
Journal of hypertension 2004;22(10):2007-15.
2004: Ibsen Hans; Wachtell Kristian; Olsen Michael H; Borch-Johnsen Knut; Lindholm Lars H; Mogensen Carl Erik; Dahlöf Björn; Devereux Richard B; de Faire Ulf; Fyhrquist Frej; Julius Stevo; Kjeldsen Sverre E; Lederballe-Pedersen Ole; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wan Ying;
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
Journal of hypertension 2004;22(9):1805-11.
2004: Reims Henrik M; Fossum Eigil; Høieggen Aud; Moan Andreas; Eide Ivar; Kjeldsen Sverre E
Adrenal medullary overactivity in lean, borderline hypertensive young men.
American journal of hypertension 2004;17(7):611-8.
2004: Svilaas Arne; Kjeldsen Sverre E; Midtbø Kjell; Westheim Arne; Syvertsen Jan Otto
[Prevention of myocardial infarction and stroke with statins]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(13-14):1821.
2004: Okin Peter M; Devereux Richard B; Nieminen Markku S; Jern Sverker; Oikarinen Lasse; Viitasalo Matti; Toivonen Lauri; Kjeldsen Sverre E; Julius Stevo; Snapinn Steven; Dahlöf Björn;
Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients.
Hypertension 2004;44(1):48-54.
2004: Weber Michael A; Julius Stevo; Kjeldsen Sverre E; Brunner Hans R; Ekman Steffan; Hansson Lennart; Hua Tsushung; Laragh John H; McInnes Gordon T; Mitchell Lada; Plat Francis; Schork M Anthony; Smith Beverly; Zanchetti Alberto
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.
Lancet 2004;363(9426):2049-51.
2004: Julius Stevo; Kjeldsen Sverre E; Weber Michael; Brunner Hans R; Ekman Steffan; Hansson Lennart; Hua Tsushung; Laragh John; McInnes Gordon T; Mitchell Lada; Plat Francis; Schork Anthony; Smith Beverly; Zanchetti Alberto;
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Lancet 2004;363(9426):2022-31.
2004: Reims H M; Kjeldsen S E; Brady W E; Dahlöf B; Devereux R B; Julius S; Beevers G; De Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm L H; Nieminen M S; Omvik P; Oparil S; Wedel H
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study.
Journal of human hypertension 2004;18(6):381-9.
2004: Fossum E; Olsen M H; Høieggen A; Wachtell K; Reims H M; Ibsen H; Julius S; Kjeldsen S E
Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy.
Journal of human hypertension 2004;18(6):375-80.
2004: Okin P M; Devereux R B; Liu J E; Oikarinen L; Jern S; Kjeldsen S E; Julius S; Wachtell K; Nieminen M S; Dahlöf B
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
Journal of human hypertension 2004;18(6):403-9.
2004: Gerdts Eva; Omvik Per; Mo Rune; Kjeldsen Sverre E
[Hypertension and heart disease]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(6):802-5.
2004: Omvik Per; Bratland Bjørn; Gerhardsen Gerhard; Gisholt Kjell; Risanger Terje; Smedsrud Tore; Kjeldsen Sverre E
[Treatment of hypertension in patients with left ventricular hypertrophy]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(6):788-91.
2004: Julius Stevo; Alderman Michael H; Beevers Gareth; Dahlöf Björn; Devereux Richard B; Douglas Janice G; Edelman Jonathan M; Harris Katherine E; Kjeldsen Sverre E; Nesbitt Shawna; Randall Otelio S; Wright Jackson T
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study.
Journal of the American College of Cardiology 2004;43(6):1047-55.
2004: Høieggen Aud; Alderman Michael H; Kjeldsen Sverre E; Julius Stevo; Devereux Richard B; De Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Chen Cong; Dahlöf Björn;
The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
Kidney international 2004;65(3):1041-9.
2004: Svilaas Arne; Kjeldsen Sverre; Midtbø Kjell; Westheim Arne; Syvertsen Jan Otto
[Statin therapy for hypertensive patients]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(2):165-6.
2004: Reims Henrik M; Oparil Suzanne; Kjeldsen Sverre E; Devereux Richard B; Julius Stevo; Brady William E; Fyhrquist Frej; Ibsen Hans; Lindholm Lars H; Omvik Per; Wedel Hans; Beevers Gareth; de Faire Ulf; Kristianson Krister; Lederballe-Pedersen Ole; Nieminen Markku S; Dahlöf Björn;
Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study.
Blood pressure 2004;13(6):376-84.
2004: McInnes Gordon T; Kjeldsen Sverre E
Never mind the quality, feel the width--ALLHAT revisited.
Blood pressure 2004;13(6):330-4.
2004: Kjeldsen Sverre E; Os Ingrid; Hedner Thomas; Himmelmann Anders
Renal hypertensive target organ damage--new evidence emerges in diabetics and smokers.
Blood pressure 2004;13(6):324-5.
2004: Sever Peter S; Dahlöf Björn; Poulter Neil R; Wedel Hans; Beevers Gareth; Caulfield Mark; Collins Rory; Kjeldsen Sverre E; Kristinsson Arni; McInnes Gordon T; Mehlsen Jesper; Nieminen Markku; O'Brien Eoin; Ostergren Jan;
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Drugs 2004;64 Suppl 2():43-60.
2004: Hedner Thomas; Kjeldsen Sverre E; Himmelmann Anders
Valuable lessons from VALUE.
Blood pressure 2004;13(4):196-7.
2004: Reims Henrik M; Sevre Knut; Fossum Eigil; Høieggen Aud; Eide Ivar; Kjeldsen Sverre E
Plasma catecholamines, blood pressure responses and perceived stress during mental arithmetic stress in young men.
Blood pressure 2004;13(5):287-94.
2004: Fossum Eigil; Høieggen Aud; Reims Henrik M; Moan Andreas; Rostrup Morten; Eide Ivar; Kjeldsen Sverre E
High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men.
Blood pressure 2004;13(2):89-94.
2003: Kjeldsen Sverre E; Os Ingrid
Hypertension in very old people.
Journal of hypertension 2003;21(12):2249-50.
2003: Wachtell Kristian; Ibsen Hans; Olsen Michael H; Borch-Johnsen Knut; Lindholm Lars H; Mogensen Carl Erik; Dahlöf Björn; Devereux Richard B; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Julius Stevo; Kjeldsen Sverre E; Kristianson Krister; Lederballe-Pedersen Ole; Nieminen Markku S; Okin Peter M; Omvik Per; Oparil Suzanne; Wedel Hans; Snapinn Steven M; Aurup Peter
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Annals of internal medicine 2003;139(11):901-6.
2003: Cifkova R; Erdine S; Fagard R; Farsang C; Heagerty A M; Kiowski W; Kjeldsen S; Lüscher T; Mallion J M; Mancia G; Poulter N; Rahn K H; Rodicio J L; Ruilope L M; van Zwieten P; Waeber B; Williams B; Zanchetti A;
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.
Journal of hypertension 2003;21(10):1779-86.
2003: Kjeldsen Sverre E; Dahlöf Björn; Devereux Richard B; Lindholm Lars H; Nieminen Markku S; Oparil Suzanne; Wedel Hans;
Comparison of the SCOPE and LIFE results.
Journal of hypertension 2003;21(9):1772-3; author reply 1773.
2003: Devereux Richard B; Dahlöf Björn; Kjeldsen Sverre E; Julius Stevo; Aurup Peter; Beevers Gareth; Edelman Jonathan M; de Faire Ulf; Fyhrquist Frej; Helle Berg Sigrid; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Snapinn Steven; Wedel Hans;
Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
Annals of internal medicine 2003;139(3):169-77.
2003: Okin Peter M; Devereux Richard B; Jern Sverker; Kjeldsen Sverre E; Julius Stevo; Nieminen Markku S; Snapinn Steven; Harris Katherine E; Aurup Peter; Edelman Jonathan M; Dahlof Bjorn;
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
Circulation 2003;108(6):684-90.
2003: Julius Stevo; Kjeldsen Sverre E; Brunner Hans; Hansson Lennart; Platt Francis; Ekman Steffan; Laragh John H; McInnes Gordon; Schork Anthony M; Smith Beverly; Weber Michael; Zanchetti Alberto;
VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk.
American journal of hypertension 2003;16(7):544-8.
2003: Bjørnholt Jørgen V; Erikssen Gunnar; Kjeldsen Sverre E; Bodegård Johan; Thaulow Erik; Erikssen Jan
Fasting blood glucose is independently associated with resting and exercise blood pressures and development of elevated blood pressure.
Journal of hypertension 2003;21(7):1383-9.
2003: Olsen M H; Hjerkinn E; Wachtell K; Høieggen A; Bella J N; Nesbitt S D; Fossum E; Kjeldsen S E; Julius S; Ibsen H
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy.
Journal of human hypertension 2003;17(5):305-11.
2003: Kristianson Krister; Fyhrquist Frej; Devereux Richard B; Kjeldsen Sverre E; Lindholm Lars H; Lyle Paulette A; Nieminen Markku S; Snapinn Steven M
An analysis of cholesterol control and statin use in the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Clinical therapeutics 2003;25(4):1186-99.
2003: Sever Peter S; Dahlöf Björn; Poulter Neil R; Wedel Hans; Beevers Gareth; Caulfield Mark; Collins Rory; Kjeldsen Sverre E; Kristinsson Arni; McInnes Gordon T; Mehlsen Jesper; Nieminen Markku; O'Brien Eoin; Ostergren Jan;
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Lancet 2003;361(9364):1149-58.
2003: Ibsen Hans; Lindholm Lars H; Pedersen Ole Lederballe; Dahlöf Björn; Kjeldsen Sverre
[The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study]
Ugeskrift for laeger 2003;165(5):459-62.
2003: Ibsen Hans; Pedersen Ole Lederballe; Dahlöf Björn; Kjeldsen Sverre E; Lindholm Lars H
[The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study]
Ugeskrift for laeger 2003;165(5):456-9.
2003: Kjeldsen Sverre E; Fossum Eigil; Reims Henrik M; Høieggen A
Hypertension treatment and stroke prevention.
Blood pressure 2003;12(5-6):264-8.
2003: Hedner T; Himmelmann Anders; Kjeldsen Sverre E
Masked hypertension--a new entity and challenge for clinical hypertension research and management.
Blood pressure 2003;12(5-6):261-3.
2003: Himmelmann Anders; Kjeldsen Sverre E; Hedner Thomas
Recent hypertension guidelines: JNC-7 and 2003 ESH/ESC.
Blood pressure 2003;12(4):196-7.
2003: Reims Henrik; Kjeldsen Sverre E; Mancia Giuseppe
Home blood pressure monitoring.
Blood pressure 2003;12(3):187-8.
2003: Kjeldsen Sverre E; Erdine Serap; Farsang Csaba; Sleight Peter; Mancia Guiseppe
1999 WHO/ISH Hypertension Guidelines--highlights & ESH Update.
Blood pressure 2003;12(3):181-2.
2003: Kjeldsen Sverre E; Hedner Thomas; Himmelman Anders
In light of ALLHAT and ASCOT: are there benefits of statins as add-on treatment in hypertensives?
Blood pressure 2003;12(3):132-3.
2003: Höieggen Aud; Fossum Eigil; Reims Henrik; Kjeldsen Sverre E
Serum uric acid and hemorheology in borderline hypertensives and in subjects with established hypertension and left ventricular hypertrophy.
Blood pressure 2003;12(2):104-10.
2003: Hedner Thomas; Himmelmann Anders; Kjeldsen Sverre E
Contrasting messages but not contradicting results from ALLHAT and ANBP2.
Blood pressure 2003;12(2):68-9.
2002: Kjeldsen Sverre E; Dahlöf Björn; Devereux Richard B; Julius Stevo; Aurup Peter; Edelman Jonathan; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Snapinn Steven; Wedel Hans;
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
JAMA : the journal of the American Medical Association 2002;288(12):1491-8.
2002: Lindholm Lars H; Ibsen Hans; Borch-Johnsen Knut; Olsen Michael Hecht; Wachtell Kristian; Dahlöf Björn; Devereux Richard B; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Julius Stevo; Kjeldsen Sverre E; Kristianson Krister; Lederballe-Pedersen Ole; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Aurup Peter; Edelman Jonathan M; Snapinn Steven;
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2002;20(9):1879-86.
2002: Kjeldsen Sverre E; Hedner Thomas; Syvertsen Jan Otto; Lund-Johansen Per; Hansson Lennart; Lanke Jan; Lindholm Lars H; De Faire Ulf; Dahlöf Björn; Karlberg Bengt E;
Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.
Journal of hypertension 2002;20(6):1231-7.
2002: Lindholm Lars H; Ibsen Hans; Dahlöf Björn; Devereux Richard B; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Julius Stevo; Kjeldsen Sverre E; Kristiansson Krister; Lederballe-Pedersen Ole; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Aurup Peter; Edelman Jonathan; Snapinn Steven;
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):1004-10.
2002: Dahlöf Björn; Devereux Richard B; Kjeldsen Sverre E; Julius Stevo; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristiansson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans;
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):995-1003.
2002: Wachtell Kristian; Olsen Michael H; Dahlöf Björn; Devereux Richard B; Kjeldsen Sverre E; Nieminen Markku S; Okin Peter M; Papademetriou Vasilios; Mogensen Carl E; Borch-Johnsen Knut; Ibsen Hans
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
Journal of hypertension 2002;20(3):405-12.
2002: Kjeldsen Sverre E; Erdine Serap; Farsang Csaba; Sleight Peter; Mancia Guiseppe;
1999 WHO/ISH Hypertension Guidelines--highlights & ESH update.
Journal of hypertension 2002;20(1):153-5.
2002: Jonsson Gisli; Fossum Eigil; Kjeldsen Sverre E; Høieggen Aud; Os Ingrid; Eide Ivar; Westheim Arne
Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction.
Blood pressure 2002;11(6):377-84.
2002: Kjeldsen Sverre E; Hedner Thomas; Syvertsen Jan Otto; Lund-Johansen Per; Hansson Lennart;
Comparison of home and office blood pressure in treated hypertensives in the Nordic Diltiazem (NORDIL) Study.
Blood pressure 2002;11(6):371-6.
2002: Bodegard Johan; Erikssen Gunnar; Sandvik Leiv; Kjeldsen Sverre E; Bjørnholt Jørgen; Erikssen Jan E
Early versus late morning measurement of blood pressure in healthy men. A potential source of measurement bias?
Blood pressure 2002;11(6):366-70.
2001: Hildebrandt P R; Tuxen C D; Kjeldsen S E; Lund-Johansen P; Hansson L
[Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents]
Ugeskrift for laeger 2001;164(1):18-21.
2001: Kjeldsen S E; Farsang C; Sleigh P; Mancia G;
1999 WHO/ISH hypertension guidelines--highlights and esh update.
Journal of hypertension 2001;19(12):2285-8.
2001: Ross A E; Flaa A; Høieggen A; Reims H; Eide I K; Kjeldsen S E
Gender specific sympathetic and hemorrheological responses to mental stress in healthy young subjects.
Scandinavian cardiovascular journal : SCJ 2001;35(5):307-12.
2001: Reims H M; Høieggen A; Fossum E; Rostrup M; Eide I; Kjeldsen S E
Glucose disposal rates calculated from 60- to 90-minute isoglycemic hyperinsulinemic glucose clamp correlate with cardiovascular risk factors in borderline hypertensive young men.
Metabolism: clinical and experimental 2001;50(10):1175-80.
2001: Sever P S; Dahlöf B; Poulter N R; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen S E; McInnes G T; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.
Journal of human hypertension 2001;15 Suppl 1():S11-2.
2001: Kjeldsen S E; Mundal R; Sandvik L; Erikssen G; Thaulow E; Erikssen J
Supine and exercise systolic blood pressure predict cardiovascular death in middle-aged men.
Journal of hypertension 2001;19(8):1343-8.
2001: Okin P M; Devereux R B; Nieminen M S; Jern S; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen S E; Julius S; Dahlöf B
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point.
Journal of the American College of Cardiology 2001;38(2):514-20.
2001: Høieggen A; Fossum E; Moan A; Rostrup M; Eide I K; Kjeldsen S E
Biphasic effect of epinephrine on blood glucose during hyperinsulinemia in borderline hypertensive young men.
American journal of hypertension 2001;14(6 Pt 1):539-45.
2001: Zanchetti A; Hansson L; Dahlöf B; Elmfeldt D; Kjeldsen S; Kolloch R; Larochelle P; McInnes G T; Mallion J M; Ruilope L; Wedel H
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.
Journal of hypertension 2001;19(6):1149-59.
2001: Sever P S; Dahlöf B; Poulter N R; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen S E; McInnes G T; Mehlsen J; Nieminen M; O'Brien E; Ostergren J
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators.
Journal of hypertension 2001;19(6):1139-47.
2001: Kjeldsen S E; Syvertsen J O; Lund-Johansen P; Hildebrandt P; Hansson L
[Comparison of preventive effect of "new" and "old" antihypertensive agents]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(11):1374-6.
2001: Reims H; Fossum E; Kjeldsen S E; Julius S
Home blood pressure monitoring. Current knowledge and directions for future research.
Blood pressure 2001;10(5-6):271-87.
2001: Kjeldsen S E; Julius S; Hedner T; Hansson L
Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials.
Blood pressure 2001;10(4):190-2.
2001: Fossum E; Berge K E; Høieggen A; Moan A; Rostrup M; Kjeldsen S E; Eide I; Berg K
Polymorphisms in candidate genes for blood pressure regulation in young men with normal or elevated screening blood pressure.
Blood pressure 2001;10(2):92-100.
2001: Kjeldsen S E; Julius S; Brunner H; Hansson L; Henis M; Ekman S; Laragh J; McInnes G; Smith B; Weber M; Zanchetti A
Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation.
Blood pressure 2001;10(2):83-91.
2000: Kjeldsen S E; Warnold I; Hansson L;
Influence of gender on prevention of myocardial infarction by antihypertensives and acetylsalicylic acid: the HOT study.
The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 2000;3(8):35-8.
2000: Okin P M; Devereux R B; Jern S; Kjeldsen S E; Julius S; Dahlöf B
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
Hypertension 2000;36(5):766-73.
2000: Kjeldsen S E; Os I; Farsang C; Mallion J M; Hansson L; Sleight P
Treatment of hypertension in patients with type-2 diabetes mellitus.
Journal of hypertension 2000;18(9):1345-6.
2000: Kjeldsen S E; Dahlöf B; Devereux R B; Julius S; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm L H; Nieminen M S; Omvik P; Oparil S; Wedel H
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
American journal of hypertension 2000;13(8):899-906.
2000: Hansson L; Hedner T; Lund-Johansen P; Kjeldsen S E; Lindholm L H; Syvertsen J O; Lanke J; de Faire U; Dahlöf B; Karlberg B E
Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
Lancet 2000;356(9227):359-65.
2000: Kjeldsen S E; Kolloch R E; Leonetti G; Mallion J M; Zanchetti A; Elmfeldt D; Warnold I; Hansson L
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment.
Journal of hypertension 2000;18(5):629-42.
2000: Olsen M H; Fossum E; Hjerkinn E; Wachtell K; Høieggen A; Nesbitt S D; Andersen U B; Phillips R A; Gaboury C L; Ibsen H; Kjeldsen S E; Julius S
Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia.
Journal of hypertension 2000;18(1):75-81.
2000: Høieggen A; Fossum E; Moan A; Rostrup M; Eide I K; Kjeldsen S E
Effects of hyperinsulinemia on sympathetic responses to mental stress.
American journal of hypertension 2000;13(1 Pt 1):21-8.
2000: Okin P M; Jern S; Devereux R B; Kjeldsen S E; Dahlöf B;
Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
Hypertension 2000;35(1 Pt 1):13-8.
2000: Reims H; Høieggen A; Fossum E; Kjeldsen S E
Assessment of insulin sensitivity by 90 min isoglycaemic hyperinsulinaemic glucose clamp in healthy young men.
Blood pressure 2000;9(2-3):121-5.
2000: Høieggen A; Fossum E; Nesbitt S D; Palmieri V; Kjeldsen S E
Blood viscosity, plasma adrenaline and fasting insulin in hypertensive patients with left ventricular hypertrophy. ICARUS, a LIFE Substudy. Insulin CARotids US Scandinavica.
Blood pressure 2000;9(2-3):83-90.
1999: Kjeldsen S E; Midtbø K; Os I; Westheim A
[An overview of hypertension studies with calcium antagonists]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1999;119(13):1878-82.
1999: Fossum E; Høieggen A; Moan A; Rostrup M; Kjeldsen S E
Insulin sensitivity is related to physical fitness and exercise blood pressure to structural vascular properties in young men.
Hypertension 1999;33(3):781-6.
1999: Høieggen A; Fossum E; Moan A; Rostrup M; Eide I K; Kjeldsen S E
Increased forearm blood flow during glucose clamp is related neither to insulin sensitivity nor to hyperinsulinemia in borderline hypertensive young men.
Blood pressure 1999;8(4):227-32.
1999: Klemsdal T O; Moan A; Kjeldsen S E
Effects of selective angiotensin II type 1 receptor blockade with losartan on arterial compliance in patients with mild essential hypertension.
Blood pressure 1999;8(4):214-9.
1998: Dahlöf B; Devereux R B; Julius S; Kjeldsen S E; Beevers G; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm L H; Nieminen M S; Omvik P; Oparil S; Wedel H
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
Hypertension 1998;32(6):989-97.
1998: Høieggen A; Fossum E; Moan A; Eide I K; Kjeldsen S E
Insulin modifies the glucose response to mental stress independently of forearm blood flow.
Blood pressure 1998;7(5-6):291-8.
1998: Fossum E; Høieggen A; Moan A; Rostrup M; Nordby G; Kjeldsen S E
Relationship between insulin sensitivity and maximal forearm blood flow in young men.
Hypertension 1998;32(5):838-43.
1998: Seljeflot I; Moan A; Aspelin T; Tønnessen T; Kjeldsen S E; Arnesen H
Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type 1 angiotensin receptor antagonist or placebo.
Metabolism: clinical and experimental 1998;47(3):292-6.
1998: Høieggen A; Fossum E; Moan A; Enger E; Kjeldsen S E
Whole-blood viscosity and the insulin-resistance syndrome.
Journal of hypertension 1998;16(2):203-10.
1998: Mundal R; Kjeldsen S E; Sandvik L; Erikssen G; Thaulow E; Erikssen J
Clustering of coronary risk factors with increasing blood pressure at rest and during exercise.
Journal of hypertension 1998;16(1):19-22.
1997: Mundal R; Kjeldsen S E; Sandvik L; Erikssen G; Thaulow E; Erikssen J
Seasonal covariation in physical fitness and blood pressure at rest and during exercise in healthy middle-aged men.
Blood pressure 1997;6(5):269-73.
1997: Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm L H; Nieminen M S; Omvik P; Oparil S; Wedel H
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
American journal of hypertension 1997;10(7 Pt 1):705-13.
1997: von Brandis P; Kjeldsen S E; Gjesdal K
[Sudden cardiac death in hypertension]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1997;117(16):2337-40.
1997: Fossum E; Høieggen A; Moan A; Nordby G; Velund T L; Kjeldsen S E
Whole blood viscosity, blood pressure and cardiovascular risk factors in healthy blood donors.
Blood pressure 1997;6(3):161-5.
1997: Mundal R; Kjeldsen S E; Sandvik L; Erikssen G; Thaulow E; Erikssen J
Predictors of 7-year changes in exercise blood pressure: effects of smoking, physical fitness and pulmonary function.
Journal of hypertension 1997;15(3):245-9.
1997: Fossum E; Høieggen A; Moan A; Nordby G; Kjeldsen S E
Insulin sensitivity relates to other cardiovascular risk factors in young men: validation of some modifications of the hyperinsulinaemic, isoglycaemic glucose clamp technique.
Blood pressure. Supplement 1997;2():113-9.
1996: Moan A; Høieggen A; Seljeflot I; Risanger T; Arnesen H; Kjeldsen S E
The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity.
Journal of hypertension 1996;14(9):1093-7.
1996: Kjeldsen S E; Syvertsen J O; Hedner T
Cardiac conduction with diltiazem and beta-blockade combined. A review and report on cases.
Blood pressure 1996;5(5):260-3.
1996: Mundal R; Kjeldsen S E; Sandvik L; Erikssen G; Thaulow E; Erikssen J
Exercise blood pressure predicts mortality from myocardial infarction.
Hypertension 1996;27(3 Pt 1):324-9.
1996: Kjeldsen S E; Moan A; Petrin J; Weder A B; Julius S
Effects of increased arterial epinephrine on insulin, glucose and phosphate.
Blood pressure 1996;5(1):27-31.
1996: Moan A; Eide I K; Kjeldsen S E
Metabolic and adrenergic characteristics of young men with insulin resistance.
Blood pressure. Supplement 1996;1():30-7.
1995: Moan A; Høieggen A; Nordby G; Eide I K; Kjeldsen S E
Effects of losartan on insulin sensitivity in severe hypertension: connections through sympathetic nervous system activity?
Journal of human hypertension 1995;9 Suppl 5():S45-50.
1995: Moan A; Høieggen A; Nordby G; Birkeland K; Eide I; Kjeldsen S E
The glucose clamp procedure activates the sympathetic nervous system even in the absence of hyperinsulinemia.
The Journal of clinical endocrinology and metabolism 1995;80(11):3151-4.
1995: Moan A; Høieggen A; Nordby G; Os I; Eide I; Kjeldsen S E
Mental stress increases glucose uptake during hyperinsulinemia: associations with sympathetic and cardiovascular responsiveness.
Metabolism: clinical and experimental 1995;44(10):1303-7.
1995: Nordby G; Moan A; Kjeldsen S E; Eide I K; Os I
Insulin resistance and sympathetic nervous system activity in hypertensive and normotensive premenopausal women.
Blood pressure 1995;4(5):287-92.
1995: Beckmann S L; Os I; Kjeldsen S E; Eide I K; Westheim A S; Hjermann I
Effect of dietary counselling on blood pressure and arterial plasma catecholamines in primary hypertension.
American journal of hypertension 1995;8(7):704-11.
1995: Kjeldsen S E; Weder A B; Egan B; Neubig R; Zweifler A J; Julius S
Effect of circulating epinephrine on platelet function and hematocrit.
Hypertension 1995;25(5):1096-105.
1995: Nordby G; Moan A; Kjeldsen S E; Os I
Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal women.
American journal of hypertension 1995;8(5 Pt 1):439-44.
1995: Moan A; Nordby G; Rostrup M; Eide I; Kjeldsen S E
Insulin sensitivity, sympathetic activity, and cardiovascular reactivity in young men.
American journal of hypertension 1995;8(3):268-75.
1994: Mundal R; Kjeldsen S E; Sandvik L; Erikssen G; Thaulow E; Erikssen J
Exercise blood pressure predicts cardiovascular mortality in middle-aged men.
Hypertension 1994;24(1):56-62.
1994: Moan A; Risanger T; Eide I; Kjeldsen S E
The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension.
Blood pressure 1994;3(3):185-8.
1994: Kjeldsen S E; Zweifler A J; Petrin J; Weder A B; Julius S
Sympathetic nervous system involvement in essential hypertension: increased platelet noradrenaline coincides with decreased beta-adrenoreceptor responsiveness.
Blood pressure 1994;3(3):164-71.
1994: Moan A; Nordby G; Os I; Birkeland K I; Kjeldsen S E
Relationship between hemorrheologic factors and insulin sensitivity in healthy young men.
Metabolism: clinical and experimental 1994;43(4):423-7.
1993: Rostrup M; Westheim A; Kjeldsen S E; Eide I
Cardiovascular reactivity, coronary risk factors, and sympathetic activity in young men.
Hypertension 1993;22(6):891-9.
1993: Mundal H H; Nordby G; Lande K; Gjesdal K; Kjeldsen S E; Os I
Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women.
Scandinavian journal of clinical and laboratory investigation 1993;53(6):585-91.
1993: Kjeldsen S E; Moan A; Rostrup M; Nordby G; Os I; Eide I
[White coat hypertension and blood pressure measurement at home]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1993;113(15):1839-43.
1993: Kjeldsen S E; Petrin J; Weder A B; Julius S
Contrasting effects of epinephrine on forearm hemodynamics and arterial plasma norepinephrine.
American journal of hypertension 1993;6(5 Pt 1):369-75.
1993: Kjeldsen S E; Moan A; Petrin J; Weder A B; Zweifler A J; Julius S
Evaluation of self-measured home vs. clinic intra-arterial blood pressure.
Blood pressure 1993;2(1):28-34.
1993: Kjeldsen S E; Syvertsen J O; Lund-Johansen P
[Can treatment of hypertension prevent myocardial infarction? New controlled clinical trials are proposed]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1993;113(6):737-40.
1993: Os I; Kjeldsen S E; Nordby G; Eide I; Lande K; Hjermann I; Westheim A
Sex differences in essential hypertension.
Journal of internal medicine 1993;233(1):13-9.
1992: Nordby G; Os I; Kjeldsen S E; Eide I
Mild essential hypertension in nonobese premenopausal women is characterized by low renin.
American journal of hypertension 1992;5(9):579-84.
1992: Moan A; Kjeldsen S E; Nordby G; Os I; Eide I; Enger E
[Treatment of hypertension in the elderly]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(17):2221-4.
1992: Kjeldsen S E; Gupta R K; Krause L; Weder A B; Julius S
Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
American heart journal 1992;123(5):1433-8.
1992: Moan A; Kjeldsen S E; Enger E; Ibsen H; Dahlöf B; Lund-Johansen P
[Treatment of hypertension in Norway. Indications, therapeutic intensity and economic aspects]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(1):69-70.
1992: Westheim A; Os I; Thaulow E; Kjeldsen S E; Eritsland J; Eide I K
Haemodynamic and neurohumoral effects of cold pressor test in severe heart failure.
Clinical physiology (Oxford, England) 1992;12(1):95-106.
1992: Kjeldsen S E; Rostrup M; Moan A; Mundal H H; Gjesdal K; Eide I K
The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension.
Journal of cardiovascular pharmacology 1992;20 Suppl 8():S32-9.
1991: Kjeldsen S E; Rostrup M; Gjesdal K; Eide I
The epinephrine-blood platelet connection with special reference to essential hypertension.
American heart journal 1991;122(1 Pt 2):330-6.
1991: Julius S; Krause L; Schork N J; Mejia A D; Jones K A; van de Ven C; Johnson E H; Sekkarie M A; Kjeldsen S E; Petrin J
Hyperkinetic borderline hypertension in Tecumseh, Michigan.
Journal of hypertension 1991;9(1):77-84.
1991: Gupta R K; Kjeldsen S E; Motley E; Weder A B; Zweifler A J; Julius S
Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
Journal of cardiovascular pharmacology 1991;17(1):13-9.
1990: Julius S; Mejia A; Jones K; Krause L; Schork N; van de Ven C; Johnson E; Petrin J; Sekkarie M A; Kjeldsen S E
"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.
Hypertension 1990;16(6):617-23.
1990: Husebye E; Kjeldsen S E; Lande K; Gjesdal K; Os I; Eide I
Increased arterial adrenaline is related to pain in uncomplicated myocardial infarction.
Journal of internal medicine 1990;228(6):617-22.
1990: Westheim A; Os I; Kjeldsen S E; Fønstelien E; Eide I K
Renal haemodynamic and sympathetic responses to head-up tilt in essential hypertension.
Scandinavian journal of clinical and laboratory investigation 1990;50(8):815-22.
1990: Rostrup M; Kjeldsen S E; Eide I K
Awareness of hypertension increases blood pressure and sympathetic responses to cold pressor test.
American journal of hypertension 1990;3(12 Pt 1):912-7.
1990: Ekeberg O; Kjeldsen S E; Greenwood D T; Enger E
Correlations between psychological and physiological responses to acute flight phobia stress.
Scandinavian journal of clinical and laboratory investigation 1990;50(6):671-7.
1990: Gupta R K; Kjeldsen S E; Krause L; Kneisley J; Posvar E; Weder A B; Julius S
Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.
Clinical pharmacology and therapeutics 1990;48(1):41-9.
1990: Kjeldsen S E; Sejersted O M; Frederichsen P; Leren P; Eide I K
Increased erythrocyte magnesium in never treated essential hypertension.
American journal of hypertension 1990;3(7):573-5.
1990: Kjeldsen S E; Sejersted O M; Frederichsen P; Leren P; Eide I K
Increased erythrocyte magnesium content in essential hypertension.
Scandinavian journal of clinical and laboratory investigation 1990;50(4):395-400.
1990: Rostrup M; Mundal H H; Kjeldsen S E; Gjesdal K; Eide I
Awareness of high blood pressure stimulates platelet release reaction.
Thrombosis and haemostasis 1990;63(3):367-70.
1990: Ekeberg O; Kjeldsen S E; Eide I K; Greenwood D T; Enger E
Effects of beta 1- and beta 2-blockade on blood pressure and sympathetic responses to flight phobia stress.
Clinical pharmacology and therapeutics 1990;47(5):599-607.
1989: Kjeldsen S E; Sejersted O M; Frederichsen P; Leren P; Eide I K
Increased erythrocyte magnesium in untreated essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S156-7.
1989: Kjeldsen S E; Neubig R R; Weder A B; Zweifler A J
The hypertension-coronary heart disease dilemma: the catecholamine-blood platelet connection.
Journal of hypertension 1989;7(11):851-60.
1989: Kjeldsen S E; Schork N J; Leren P; Eide I K
Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension.
American heart journal 1989;118(4):775-81.
1989: Lande K; Os I; Kjeldsen S E; Westheim A; Hjermann I; Eide I; Gjesdal K
Effect of dopamine and dopamine-antagonist infusion on blood platelet count, size and release reaction in hypertensive and normotensive subjects.
Scandinavian journal of clinical and laboratory investigation 1989;49(4):307-15.
1989: Ekeberg O; Ellertsen B B; Seeberg I; Kjeldsen S E
Plasma catecholamines in some airline passengers.
Scandinavian journal of clinical and laboratory investigation 1989;49(2):183-8.
1988: Kjeldsen S E; Os I; Westheim A; Lande K; Gjesdal K; Hjermann I; Eide I
Hyper-responsiveness to low-dose epinephrine infusion in mild essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S581-3.
1988: Kjeldsen S E; Gjesdal K; Leren P; Eide I K
Decreased platelet-free dopamine and unchanged noradrenaline and adrenaline in essential hypertension.
Thrombosis and haemostasis 1988;60(2):251-4.
1988: Kjeldsen S E; Os I; Westheim A; Frederichsen P; Hjermann I; Eide I K; Gautvik K
Decreased serum phosphate in essential hypertension. Related to increased sympathetic tone.
American journal of hypertension 1988;1(4 Pt 1):403-9.
1988: Beckmann S L; Os I; Kjeldsen S E; Mogensen B; Norum K R; Hjermann I
[Non-pharmacological treatment of mild to moderate hypertension. A randomized, controlled study--results 1 1/2 years later]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1988;108(22):1593-7.
1988: Kjeldsen S E; Westheim A; Lande K; Gjesdal K; Leren P; Enger E; Eide I K
Sodium depletion increases platelet and plasma catecholamines in hypertensive men.
Hypertension 1988;11(5):477-82.
1988: Lande K; Kjeldsen S E; Os I; Westheim A; Hjermann I; Eide I; Gjesdal K
Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension.
Journal of hypertension 1988;6(3):219-25.
1987: Lande K; Kjeldsen S E; Eide I; Leren P; Gjesdal K
Does increased platelet release normalize during anti-hypertensive treatment?
Thrombosis and haemostasis 1987;58(3):834-8.
1987: Myreng Y; Lande K; Kjeldsen S E; Eide I; Grendahl H; Gjesdal K
Increase in beta-thromboglobulin during exercise.
Thrombosis research 1987;48(1):111-5.
1987: Lande K; Os I; Kjeldsen S E; Westheim A; Hjermann I; Eide I; Gjesdal K
Increased platelet size and release reaction in essential hypertension.
Journal of hypertension 1987;5(4):401-6.
1987: Os I; Kjeldsen S E; Westheim A; Aakesson I; Norman N; Enger E; Hjermann I; Eide I
Decreased central dopaminergic activity in essential hypertension.
Journal of hypertension 1987;5(2):191-7.
1987: Os I; Kjeldsen S E; Beckmann S L; Eide I; Hjermann I; Leren P; Westheim A
[Sodium restriction in hypertension. Sympathetic tonus, renin and vasopressin]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1987;107(10-11):954-7.
1987: Kjeldsen S E; Taylor I; Westheim A; Foss O P; Leren P; Eide I K
Severe sodium restriction alone and with potassium supplementation does not alter blood lipoproteins in essential hypertension.
European journal of clinical investigation 1987;17(2):182-6.
1987: Kjeldsen S E; Lande K; Gjesdal K; Westheim A; Foss O P; Leren P; Eide I K
Increased platelet release reaction in 50-year-old men with essential hypertension: correlation with atherogenic cholesterol fractions.
American heart journal 1987;113(1):151-5.
1987: Os I; Kjeldsen S E; Westheim A; Akesson I; Eide I; Skjøtø J; Hjermann I; Leren P
Aging and urinary vasopressin excretion in healthy men.
Scandinavian journal of urology and nephrology 1987;21(3):235-9.
1986: Kjeldsen S E; Lande K; Gjesdal K; Jackson M B; Westheim A; Frederichsen P; Leren P; Eide I
Increased plasma noradrenaline during severe sodium restriction does not stimulate platelet release in essential hypertension.
Thrombosis and haemostasis 1986;56(2):120-3.
1986: Kjeldsen S E; Westheim A; Aakesson I; Eide I; Leren P
Plasma adrenaline and noradrenaline during orthostasis in man: the importance of arterial sampling.
Scandinavian journal of clinical and laboratory investigation 1986;46(5):397-401.
1986: Oian P; Lande K; Kjeldsen S E; Gjesdal K; Aakesson I; Eide I; Maltau J M
Enhanced platelet release reaction related to arterial plasma adrenaline and blood pressure in pre-eclampsia.
British journal of obstetrics and gynaecology 1986;93(6):548-53.
1986: Os I; Kjeldsen S E; Skjøtø J; Westheim A; Lande K; Aakesson I; Frederichsen P; Leren P; Hjermann I; Eide I K
Increased plasma vasopressin in low renin essential hypertension.
Hypertension 1986;8(6):506-13.
1986: Os I; Kjeldsen S E; Westheim A; Jackson M B; Aakesson I; Frederichsen P; Leren P; Eide I
Hormonal responses to treatment of high blood pressure with low-salt diet alone and combined with added potassium.
Acta medica Scandinavica. Supplementum 1986;714():93-7.
1986: Os I; Kjeldsen S E; Westheim A; Jackson M B; Akesson I; Frederichsen P; Eide I; Leren P
The effect of sodium depletion and potassium supplementation on vasopressin, renin and catecholamines in hypertensive men.
Acta medica Scandinavica 1986;220(3):195-203.
1986: Kjeldsen S E; Eide I; Os I; Westheim A; Aakesson I; Børre Mogensen S; Frederichsen P; Hjermann I; Gautvik K
Serum phosphate and sympathetic tone in mild essential hypertension.
Acta medica Scandinavica. Supplementum 1986;714():119-23.
1986: Os I; Kjeldsen S E; Westheim A; Normann N; Aakesson I; Hjermann I; Eide I
Central dopaminergic control of prolactin in essential hypertension.
Acta medica Scandinavica. Supplementum 1986;714():113-7.
1986: Lande K; Os I; Kjeldsen S E; Westheim A; Aakesson I; Hjermann I; Eide I; Gjesdal K
Platelet volume, platelet release reaction and platelet response to infused adrenaline are increased in essential hypertension.
Acta medica Scandinavica. Supplementum 1986;714():129-32.
1986: Gjesdal K; Kjeldsen S E; Lande K; Westheim A; Aakesson I; Foss O P; Leren P; Eide I K
Blood platelet release correlates with serum lipids in 50 year old men with essential hypertension.
Acta medica Scandinavica. Supplementum 1986;714():125-8.
1985: Kjeldsen S E; Eide I; Aakesson I; Oian P; Maltau J M; Lande K; Gjesdal K
Increased arterial adrenaline is highly correlated to blood pressure and in vivo platelet function in pre-eclampsia.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1985;3(3):S93-5.
1985: Kjeldsen S E; Os I; Forsberg G; Aakesson I; Skjøtø J; Frederichsen P; Fønstelien E; Eide I
Dietary sodium intake increases vasopressin secretion in man.
Journal of clinical hypertension 1985;1(2):123-31.
1985: Os I; Kjeldsen S E; Aakesson I; Skjøtø J; Eide I; Hjermann I; Leren P
Evidence of age-related variation in plasma vasopressin of normotensive men.
Scandinavian journal of clinical and laboratory investigation 1985;45(3):263-8.
1984: Kjeldsen S E; Forsberg G; Eide I; Aakesson I; Os I; Skjøtø J; Frederichsen P
Dietary sodium intake and vasopressin excretion in man.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1984;2(3):S301-3.
1984: Os I; Kjeldsen S E; Aakesson I; Skjøtø J; Westheim A; Eide I; Leren P
Arteriovenous difference of plasma vasopressin in normal man and effect of posture.
Acta physiologica Scandinavica 1984;122(1):49-53.
1984: Skjøtø J; Aakesson I; Os I; Kjeldsen S E; Eide I; Leren P
Increased plasma vasopressin and serum uric acid in the low renin type of essential hypertension.
Acta medica Scandinavica 1984;215(2):165-72.
1983: Kjeldsen S E; Eide I; Aakesson I; Leren P
Increased arterial catecholamine concentrations in 50-year-old men with essential hypertension.
Scandinavian journal of clinical and laboratory investigation 1983;43(4):343-9.
1983: Kjeldsen S E; Eide I; Aakesson I; Leren P
Influence of body weight on plasma catecholamine patterns in middle-aged, normotensive men.
Scandinavian journal of clinical and laboratory investigation 1983;43(4):339-42.
1983: Kjeldsen S E; Eide I; Aakesson I; Amundsen R; Eriksen I L; Leren P
Increased plasma free dopamine after treatment with atenolol and oxprenolol in essential hypertension.
Acta medica Scandinavica 1983;214(5):367-71.
1983: Kjeldsen S E; Gjesdal K; Eide I; Aakesson I; Amundsen R; Foss O P; Leren P
Increased beta-thromboglobulin in essential hypertension: interactions between arterial plasma adrenaline, platelet function and blood lipids.
Acta medica Scandinavica 1983;213(5):369-73.

Sign-in to see more